In the absence of transporter inhibition, ambient [Glu] has been

In the absence of transporter inhibition, ambient [Glu] has been reported as being too low to activate AMPA receptors,

selleck inhibitor even when desensitization is pharmacologically blocked (Le Meur et al., 2007). In contrast, ambient [Glu] has been reported to tonically activate high-affinity NMDA receptors (Sah et al., 1989, Cavelier and Attwell, 2005, Le Meur et al., 2007 and Herman and Jahr, 2007). Several patch clamp studies in acute hippocampal slice have provided estimates of ambient [Glu] based on analyses of the tonic NMDA receptor currents in CA1 pyramidal neurons. These have been reported as ∼25 nM at 32° (Herman and Jahr, 2007), 27–33 nM at 25° and 77–89 nM at 35° (Cavelier and Attwell, 2005), and 83–87 nM at 25° (Le Meur et al., 2007). These estimates are not likely to be artifactually low due to loss of glutamate from the surface of the slice, because inclusion of 2 μM glutamate in the recording chamber did not alter the level of tonic receptor activity (Herman and Jahr, 2007). The major source of glutamate in these studies was of non-vesicular origin. A range of possible molecular mechanisms may underlie glutamate release, including glutamate-permeable anion channels, the cystine-glutamate exchanger xCT, and passive membrane diffusion (Kimelberg et al., 1990, Baker

et al., 2002 and Cavelier and Attwell, 2005; for review see Cavelier et al., 2005). Elevation of ambient [Glu] by inhibition Vemurafenib price of glutamine synthetase

suggests that a major contribution of glutamate release is from glia (Cavelier and Attwell, 2005 and Le Meur et al., 2007). The data and the diffusion model presented here suggests that a thin layer of damaged tissue with disrupted glutamate transport could underlie the significant quantitative discrepancy between the ambient glutamate estimates provided by electrophysiological studies in slices and those from microdialysis studies, which generally report ambient [Glu] values in the range ⩾2 μM (reviewed by Cavelier et al., 2005 and Featherstone and Shippy, 2008). Histological analyses of tissue surrounding microdialysis 17-DMAG (Alvespimycin) HCl probes provide evidence for a layer of damaged tissue up to hundreds of microns surrounding the probe (Clapp-Lilly et al., 1999, Bungay et al., 2003, Amina et al., 2003 and Jaquins-Gerstl and Michael, 2009). Diffusion modeling suggests that disrupted transport in this region could lead to artifactually large concentrations in the probe volume. A critical assumption in our model is that the glutamate leak source is constant in a volume of metabolically damaged tissue where transport is impaired. The precise spatial changes in metabolic activity in a traumatized or ischemic region of tissue are unknown, but the assumption that the leak is constant is conservative. For example, glutamate release is increased by reversed glutamate transport due to impaired Na/K gradients during metabolic challenge (Rossi et al., 2000).

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>